Dergiler / European Journal of Breast Health / 2022 / Cilt: 18 - Sayı: 1

The Importance of Superb Microvascular Imaging for the Differentiation of Malignant Breast Lesions from Benign Lesions

Sayfa
48–54
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Comparison of VI values from a lesion and from normal breast tissue showed that VI values in malignant lesions were significantly higher (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: In this prospective study, the diagnostic performance of the new version of superb microvascular imaging (SMI) in differentiating malignant from benign lesions was evaluated.
📊
Temel Bulgular & Veri:Results: The cut-off value, in the differentiation of benign and malignant lesions with color SMI was 0.50 for box ROI, while it was 0.30 for free-hand ROI.
💡
Sonuç & Katkı:Comparison of VI values from a lesion and from normal breast tissue showed that VI values in malignant lesions were significantly higher (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: In this prospective study, the diagnostic performance of the new version of superb microvascular imaging (SMI) in differentiating malignant from benign lesions was evaluated. Material and Methods: Ninety breast lesions were included. During color SMI examination, both free-hand region of interest (ROI) and box ROI were used. Vascular index (VI) values were obtained from the lesion using both types of ROI and from normal breast tissue via box ROI. VI values, monochrome SMI grading and histopathological results were compared. The efficacy of color SMI and monochrome SMI was investigated in differentiating between benign and malignant breast lesions. Results: The cut-off value, in the differentiation of benign and malignant lesions with color SMI was 0.50 for box ROI, while it was 0.30 for free-hand ROI. The specificity of VI values obtained with box ROI was higher than that of free-hand ROI when differentiating malignant lesions from benign. Comparison of VI values from a lesion and from normal breast tissue showed that VI values in malignant lesions were significantly higher (p

🔖

Bu Makaleye Atıf Yap

BAYRAMOĞLU, Z., ALTUNKESER, A., ARSLAN, F. Z., KARAGÜLLE, M., KÖREZ, M. K., AKSOY, N. (2022). The Importance of Superb Microvascular Imaging for the Differentiation of Malignant Breast Lesions from Benign Lesions. European Journal of Breast Health, Cilt: 18 - Sayı: 1, 48–54. https://ajindex.com/articles/510665

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997
  2. [Crossref ] 2. Martin FT, O’Fearraigh C, Hanley C, Curran C, Sweeney KJ, Kerin MJ. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index. Breast J 2013
  3. (PMID: 23721403) [Crossref ] 3. Fox SB, Generali DG, Harris AL. Breast tumour angiogenesis. Breast Cancer Res 2007
  4. (PMID: 18190723) [Crossref ] 4. Stanzani D, Chala LF, Barros Nd, Cerri GG, Chammas MC. Can Doppler or contrast-enhanced ultrasound analysis add diagnostically important information about the nature of breast lesions? Clinics 2014
  5. (PMID: 24519198) [Crossref ] 5. Bakdik S, Arslan S, Oncu F, Durmaz MS, Altunkeser A, Eryilmaz MA. Effectiveness of Superb Microvascular Imaging for the differentiation of intraductal breast lesions. Med Ultrason 2018
  6. (PMID: 30167583) [Crossref ] 6. Machado P, Segal S, Lyshchik A, Forsberg F. A Novel Microvascular Flow Technique: Initial Results in Thyroids. Ultrasound Q 2016
  7. (PMID: 25900162) [Crossref ] 7. Kono T, Kazutoshi F, Gen N. Superb Micro-Vascular Imaging (SMI): clinical advantages of a novel us flow technique in pe- diatric diagnostic Imaging. AOSPR 2017
  8. [Crossref ] 8. D’Orsi CJ, Sickles EA, Mendelson EB, Morris EA. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology
  9. 2013[Crossref ] 9. Shah G, Jankharia B. Pictorial essay: Breast US. Indian J Radiol Imaging 2010
  10. (PMID: 20607018) [Crossref ] 10. Altunkeser A, Arslan FZ, Eryılmaz MA. Magnetic resonance imaging findings of idiopathic granulomatous mastitis: can it be an indirect sign of treatment success or fail? BMC Med Imaging 2019
  11. (PMID: 31842782) [Crossref ] 11. Garcia M, Jemal AW, Ward EM, Center MM, Hao Y, Siegel RL et al
  12. American Cancer Society. Breast Cancer Facts & Figures 2007-2008. 2007[Crossref ] 12. Mohindra N, Neyaz Z, Agrawal V, Agarwal G, Mishra P. Impact of addition of digital breast tomosynthesis to digital mammography in lesion characterization in breast cancer patients. Int J App Basic Med Res 2018
  13. (PMID: 29552533) [Crossref ] 13. Mann RM, Cho N, Moy L. Breast MRI: state of the art. Radiology 2019
  14. (PMID: 31361209) [Crossref ] 14. Xiao XY, Chen X, Guan X